You should worry about Big Pharma's dividends

Among the top dividend stocks that I post every month, many of the top payers are pharmaceutical companies that are in the business of doing research, inventing and then marketing drugs that will solve all types of problems. These companies typically have strong balance sheets and certainly look like very attractive dividend stocks. We decided to take a deeper look into these stocks to see if they were worth holding in a diversified dividend portfolio.

In my opinion, the conclusion is not to avoid pharma companies but rather to avoid a high concentration of pharma stocks in a dividend portfolio. Those stocks, like financials, carry their load of risk right now. They are good dividend payers and might remain so in the future. But be careful and do not include most of your stocks in this portfolio.

Source: Intelligent Speculator

Related Articles:

• Increasing Dividend Yield Part II: REITs
• Low-Debt Dividend Stocks
• Is Your Portfolio Average?
• 3 High-Yield Telecom Dividend Stocks
• International Diversification Begins At Home